14 ms·
Moderna is working on a vaccine targeting the Omicron variant for 2022.[1] The mRNA vaccine technology is "agile". There's a workflow from sequencing a virus t
by Animats 5y ago
Moderna is working on a vaccine targeting the Omicron variant for 2022.[1]
The mRNA vaccine technology is "agile". There's a workflow from sequencing a virus to generating a candidate vaccine. It only took two days to generate the original COVID-19 vaccine. It's the clinical testing in small, then large groups that's the time consuming part.
Also, the inhaled vaccines are entering clinical testing.[2] It's not like we're stuck with the original vaccines.
[1] https://www.cnbc.com/2021/11/28/moderna-says-an-omicron-variant-vaccine-could-be-ready-in-early-2022.html https://www.cnbc.com/2021/11/28/moderna-says-an-omicron-vari...
[2] https://www.thetimes.co.uk/article/e1637976-5c3f-11ec-90d0-c463baf3512f https://www.thetimes.co.uk/article/e1637976-5c3f-11ec-90d0-c...
- liber8 5y agoAccording to reports, the original BioNTech vaccine was developed in a matter of hours: https://www.businessinsider.com/pfizer-biontech-vaccine-designed-in-hours-one-weekend-2020-12 https://www.businessinsider.com/pfizer-biontech-vaccine-desi... Moderna's was done in two days.
- starik36 5y agoRight, but the underlying tech was in development for a decade or more. I can deploy an app to Azure, tell it to allocate a server farm, databases, Redis, queues, etc... in 5 minutes too. But that's only because someone took years to do all the necessary work.
- johnisgood 5y ago> but the underlying tech was in development for a decade or more. By tech you mean mRNA vaccines? How did those studies go about it? Why was it not a thing before COVID-19?
- barbazoo 5y agoHave a look at https://en.wikipedia.org/wiki/MRNA_vaccine https://en.wikipedia.org/wiki/MRNA_vaccine for an idea of a timeline going back to the 60s.
- exegete 5y agomRNA vaccines have been a thing in labs for a few decades and first human clinical trials against a pathogen in 2013 https://en.m.wikipedia.org/wiki/MRNA_vaccine https://en.m.wikipedia.org/wiki/MRNA_vaccine
- johnisgood 5y ago> Before 2020, no mRNA technology platform (drug or vaccine) had been authorized for use in humans, so there was a risk of unknown effects.[79] The 2020 COVID-19 pandemic required faster production capability of mRNA vaccines, made them attractive to national health organisations, and led to debate about the type of initial authorization mRNA vaccines should get (including emergency use authorization or expanded access authorization) after the eight-week period of post-final human trials. That risk of unknown effects was still there even when it got authorized for emergency use. Has it changed yet? Like... there was a vaccine based on old tech that has been used in humans for decades without side-effects that caused narcolepsy a year or two later, and we got lucky to have been able to make the association. It is not really only about what tech it uses, apparently.
- epylar 5y agoAre you talking about Pandemrix? https://www.cdc.gov/vaccinesafety/concerns/history/narcolepsy-flu.html https://www.cdc.gov/vaccinesafety/concerns/history/narcoleps... says there was a lot of follow up on that and no link to narcolepsy was found
- deleted 5y ago[deleted]
- johnisgood 5y agoAbout particularly that, Wikipedia says "In 2018, a multinational study including Centers for Disease Control and Prevention scientists published safety data on adjuvanted pH1N1 vaccines. Sweden was the only country where increased narcolepsy IRs were found in the period after vaccination campaigns. The ability of the researchers to evaluate the Pandremix brand vaccine was limited.", but you can read other ones as well here: https://en.wikipedia.org/wiki/Pandemrix#Narcolepsy https://en.wikipedia.org/wiki/Pandemrix#Narcolepsy It is quite interesting.
- marco_yolo 5y agowhy would you deploy an app to azure?
- erhk 5y agoProbably because you paid them to let you.
- throwaway984393 5y agoLeverage
- stjohnswarts 5y agoSure but the delta amount of time is tiny compared to the 10 years to development so OP is correct as he never asserted that they were starting from scratch
- vimy 5y agoWhich makes me wonder why it takes so long this time?
- data_dan_ 5y agoTesting and clinical trials!
- vimy 5y agoWe don’t do clinical trials for the yearly flu vaccine update, do we?
- s1artibartfast 5y agoWe also have 80 years of experience with the flu vaccine opposed to 8 months
- SECProto 5y ago> We also have 80 years of experience with the flu vaccine opposed to 8 months 8 months is incorrect. Here's[1] an article from 17 months ago about results from Moderna's covid-19 trials for vaccinations dating back to mar16 2020. So it's been 21 months, not 8 (and that's ignoring trials of mRNA vaccines years earlier as they weren't for this specific virus) [1] https://www.cidrap.umn.edu/news-perspective/2020/07/hopeful-results-phase-1-moderna-covid-vaccine-trial https://www.cidrap.umn.edu/news-perspective/2020/07/hopeful-...
- s1artibartfast 5y agoWe can split hairs on what constitutes experience, or when it starts. but the point still stands: We have a lot more experience with the flu vaccine. This is the answer for why not all annual flu vaccines need clinical trials.
- ashildr 5y ago
- kyleblarson 5y agoModerna CEO equity sales for the last couple years. Nothing to see here, no reason to distrust them pushing endless boosters: https://finance.yahoo.com/screener/insider/BANCEL%20STEPHANE%20J?count=100&offset=0 https://finance.yahoo.com/screener/insider/BANCEL%20STEPHANE...
- novok 5y agoExecs are paid mostly in stock, and it's a bad idea to leave all your money in one stock basket. Seeing how they are mostly round numbers on a regular schedule, it's probably a https://www.investopedia.com/terms/r/rule-10b5-1.asp https://www.investopedia.com/terms/r/rule-10b5-1.asp sale on a schedule.
- d3ad1ysp0rk 5y agoI scrolled thru the last 2 years, and honestly I'm not sure what point you're trying to make. Too much profit? Sure. I don't think the boosters are going to be what solidifies that issue for corporations though.. Some timing issue with selling? I don't see it.
- deleted 5y ago[deleted]
- marderfarker2 5y agoPharma probably learnt what worked for software: turn perpetual licenses into subscriptions. Chances are these “boosters” will become a quarterly occurrence, even when the virus pose little to no threat (to an already vaccinated person)
- x86_64Ubuntu 5y agoYou mean like the flu virus? For which doctors say that we should get every year?
- tekknik 5y ago
- wombatmobile 5y ago> The mRNA vaccine technology is "agile". Yes and this means governments can quickly adapt to new variants by reformulating the vaccine, dumping old stock by "donating" it to developing nations, or dumping it, and buying new stock from big pharma. Since developing nations will always have far lower vaccination rates than first world countries, the virus will continue to mutate and proliferate outside of America and Europe, ensuring new opportunities for revving the vaccine. That's a sustainable business model for the first world.
- tekknik 5y ago> dumping old stock by "donating" it to developing nations A primary complaint is that “rich nations” hoard vaccines. doesn’t this exacerbate this?
- wombatmobile 5y agoIf rich nations paid for poor nations to reach 95%+ vaccination levels, the virus would be tamed for everyone's benefit. With the prevailing scheme, in which rich nations fund high vax levels domestically, and allow poor nations to languish, the virus is always going to have reservoirs around the world in which it can mutate, thereby requiring new rounds of vaccination in the rich countries periodically. The total cost of vaccinating the whole world in 1 year would be far less than the cost of infinite rolling booster programs. And yet, we do the latter. Why? That's the secret sauce of the sustainable business model.
- isignal 5y agoThis is incorrect, cost of vaccines is not the only bottleneck. For example, India is currently manufacturing more vaccines than can can be sold to other countries. The bottleneck is apparently people on ground to get shots into arms. Most of the developed countries also used mRNA vaccines which needed low temperature refrigeration. Such facilities are cost prohibitive in poorer countries. Beyond all this, there’s a significant worldwide population of vaccine skeptics who will not take free vaccines at their doorstep if available.
- tekknik 5y agoYay, more injections of experimental vaccines!
- mikeyjk 5y agoWhat level of testing would make these vaccines non experimental in your mind, and what other vaccine do you know that has had that level of rigour applied? I'm genuinely curious
- raxxorrax 5y agoThe timeframe of two years is simply not enough to be entirely sure, even with the large sample size. It is unlikely to have side effects, but the demand on proof is extensive and that isn't necessarily bad.
- l8rlump 5y agoNot the OP, but for me, I'm led to believe that vaccine trials usually go for 7 years, so there's that hesitancy that yes, the sample size is huge, but the normal time hasn't elapsed. Also don't forget that at the beginning of the rollout, the rigour was much less. Thankfully so far so good (depending on who you talk to), but time makes things clearer, and down the road things will be even more clear. Combined with: * the perceived scaremongering and desperation of some governments and media; * Being a cancer survivor and not having clear, trustworthy research on effects on this subgroup (they're using genetic instructions to hijack our own cells and produce a foreign protein? That sounds really clever but it also reminds me of cancer)... alarm bells were ringing, right or wrong. I'd welcome any information that helps with my concerns. It's a genuine wrestle.
- StanislavPetrov 5y ago>What level of testing would make these vaccines non experimental in your mind, and what other vaccine do you know that has had that level of rigour applied? There's no "level of testing" except for time. The fact is that we won't know what the effects of these drugs are in 10 years until 10 years passes. We can run studies and make educated guesses about what might happen in the future but they are just that - guesses. Given the numbers from the latest study in Israel (the study that was touted as requiring the need for boosters), the odds of a double vaccinated person over 50 being hospitalized from Covid after their "immunity waned" was 2 in 10,000. The chance of death was 6 in 100,000. The chances for younger people are much lower. Given that, how much of an unknown risk is it worth taking for a "booster"? Just how much lower than 6 in 100,000 is that chance worth? Everything we do in life is a series of calculated risks. The people who want to take that risk now, or multiple times per year for the rest of their lives should be entitled to do so. But to pretend that this new, experimental mRna vaccine is risk free because we ran a few short-term trials is absurd on its face. To mandate people, let alone infants and small children who have virtually no risk, to take an endless series of these experimental shots is madness. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02249-2/fulltext https://www.thelancet.com/journals/lancet/article/PIIS0140-6...
- blub 5y agoMeanwhile, the Biontech CEO thinks that a fourth booster may be needed. For all the agility of mRNA, the reality looks like we are indeed stuck with the original vaccines. And I suspect that countries which want to implement mandatory vaccination like Austria and perhaps Germany will force people to get the now worthless first and nearly worthless second doses of the original vaccine, because anything else won't be available.